Showing 1671-1680 of 2742 results for "".
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://modernaesthetics.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- Neutrogena Recalls Makeup Wipes Due to Bacterial Contaminationhttps://modernaesthetics.com/news/neutrogena-recalls-makeup-wipes-due-to-bacterial-contamination/2484214/The Food and Drug Administration (FDA) issued a Class II risk level for a line of Neutrogena's makeup-removing facial wipes due to potential bacterial infection, according to a statement from the agency. In a brief message, the FDA reported that an internal investigation by the manufacture
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://modernaesthetics.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://modernaesthetics.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni
- PLADUOpro Plasma System Debuts in North Americahttps://modernaesthetics.com/news/pladuopro-plasma-system-debuts-in-north-america/2483995/Aesthetic Management Partners (AMP) announced the North American launch of PLADUOpro, a dual-gas plasma device designed to support noninvasive skin resurfacing and regeneration. The device, which integrates both argon and nitro
- Mayo Clinic Researchers Develop Fully Humanized 3D Bioprinted Skin Using Plant-Based Collagenhttps://modernaesthetics.com/news/mayo-clinic-researchers-develop-fully-humanized-3d-bioprinted-skin-using-plant-based-collagen/2483984/Mayo Clinic scientists have developed a fully humanized 3D bioprinted skin model using recombinant human collagen (rhCollagen) derived from plants, according to a study published in Archives of Dermatological Research.
- BTL Files Patent Infringement Lawsuit Against WonderFace Devicehttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-wonderface-device/2483957/BTL Group has filed a patent infringement claim before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the company behind the WonderFace device. The claim centers on BTL’s proprietary technology used in its EMFACE system, which integrates selective muscle
- Natural Refinement, Early Intervention Define 2026 Aesthetic Trends, Says Dr Anil Shahhttps://modernaesthetics.com/news/natural-refinement-early-intervention-define-2026-aesthetic-trends-says-dr-anil-shah/2483940/Facial plastic surgeon Anil Shah, MD, outlined six key trends shaping aesthetic surgery in 2026 in a recent press release, reflecting a shift toward holistic, age-conscious, and safety-driven approaches. A full-face rejuvenation approach is supplanting isolated interventions, according to
- GLP-1 Demand Holds Steady in Aesthetic Clinics Despite Regulatory Shiftshttps://modernaesthetics.com/news/glp-1-demand-holds-steady-in-aesthetic-clinics-despite-regulatory-shifts/2483599/Despite regulatory uncertainty and reported shortages, aesthetic practices continue to experience high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, according to a report released by Guidepoint Qsight on October 1, 2025.
- Dr. Anthony Brissett Named President of AAFPRS for 2025–2026 Termhttps://modernaesthetics.com/news/dr-anthony-brissett-named-president-of-aafprs/2483515/Anthony E. Brissett, MD, FACS, a facial plastic and reconstructive surgeon based in Houston, has been named President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) for the 2025–2026 term. His appointment was formalized during the AAFPRS Annual Business Meeting held